Global partnerships WPI has an active pattern of strategic partnerships across Europe and beyond, collaborating with ELVESYS, NETRI, and TotalLab to expand distribution and compliance capabilities. This presents sales opportunities to cross-sell instrumentation, integration services, and regional support packages in new markets.

Regulatory readiness Recent moves toward 21 CFR Part 11 compliance integration into EVOM products indicate a push to meet regulatory needs for lab data integrity. This creates upsell potential for validated software, audit-ready solutions, and enhanced documentation services to life sciences customers pursuing compliant preclinical workflows.

Expanded capabilities WPI’s product evolution includes EVOM Auto and 3D SpectaScope, highlighting strengths in automated electrophysiology and advanced imaging. Opportunities exist to bundle high-throughput workflow solutions, automation add-ons, and service contracts to research labs scaling up drug discovery and tissue modeling.

Global footprint With offices in key markets and a history of Asian and European expansion, WPI presents a channel-friendly opportunity for regional distributors, localized training, and spare parts ecosystems to support customers performing multi-region studies and organ-on-chip research.

Industry alignment Active collaborations with organ-on-chip startups (NETRI) and microfluidics specialists (ELVEFLOW) position WPI as a preferred supplier for researchers pursuing tissue biology, fluidics, and electrophysiology. This suggests targeted campaigns to academic labs and pharma groups investing in preclinical model validation and pharmacokinetic studies.